Antarctica

This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reduced Inequalities by emphasizing the importance of gender-specific medicine in pharmaceutical development and global healthcare, aiming to improve health outcomes for all genders. By addressing the challenges faced by the pharmaceutical industry in integrating knowledge on sex-specific biological differences into drug development programs, the chapter advocates for strategies to promote equity in healthcare access and outcomes. Additionally, it recognizes the importance of addressing gender disparities in healthcare and advocating for approaches that ensure equal access to gender-specific pharmaceuticals. Through these efforts, the content supports the goal of reducing inequalities in healthcare access and outcomes, ultimately contributing to the promotion of good health and well-being for all individuals, regardless of gender.
One Health and the Exposome embrace a broad view of human health and its environmental drivers as well as provide various tools and modes of operation to systematically uncover pathways linking poor health outcomes with their root causes to inform interventions supporting the WHO SDG3.
Elsevier,

Translational Surgery

Handbook for Designing and Conducting Clinical and Translational Research

2023, Pages 591-597

The extensive history of abuse and ongoing mistreatment of Black Americans continues to foster apprehension and distrust of healthcare providers. This has resulted in substantial barriers for modern healthcare to appropriately address the needs of Black patients. These concerns have been visibly manifested during the COVID-19 pandemic. This article supports WHO SDG 3 Good Health and Wellbeing and SDG10 Reduced Inequalities.
Highlights the 21st century's fundamental “global health” reformulation of PubHealth and anticolonial resistance (to a perceived cultural imperialism of the West including in PubHealth) supporting SDG 3.
The need and opportunities for global health strategies to leverage the power of digital health technology to improve healthcare outcomes are growing. Telehealth and other digital health products and services are becoming increasingly important in this effort, and methodical strategies should be used to evaluate the need, application, integration, maintenance, and scaling of such solutions. With the correct attention upon these areas, digital health can serve as a catalyst to improve healthcare outcomes and reduce disparities across the world, supporting SDG3.
Elsevier,

Clinical Decision Support and Beyond (Third Edition)

Progress and Opportunities in Knowledge-Enhanced Health and Healthcare

2023, Pages 707-714

Clinical Decision support provides an effective tool to minimize many of the drivers of health disparities in healthcare. There is promising evidence that these tools can serve to promote equity across the healthcare spectrum supporting SDG 3. However, future iterations require a focus on equity from the start and inclusive and sustainable development, implementation, and evaluation practices.
Drug resistance became widely recognized global threats in last two decades. Knowledge of drug resistance, development of new vaccines and medicines, public awareness program, government support (policies and incentive), development of new diagnostic tool, industrial support in medical research are the need of the hour that will help the mankind to fight back and deal with drug resistance and helps to support SDG3.
Elsevier,

The New Public Health (Fourth Edition)

2023, Pages 467-549

This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reduced Inequalities by recognizing the importance of addressing health needs across various life stages within the family unit, emphasizing the significance of equal rights and access to healthcare for women, children, and men. It underscores the role of family and community support in promoting health through factors such as nutrition, education, and social and mental well-being, contributing to the overall health and well-being of individuals. Additionally, the discussion of the impact of aging on both individuals and families highlights the need for comprehensive health and social support systems to address the challenges associated with aging, thereby promoting good health and well-being for all members of society. Furthermore, acknowledges the influence of social inequities, poverty, and other factors such as displacement and mass trauma on family health. By advocating for the reduction of poverty and the provision of social support systems, the content supports efforts to reduce inequalities in access to healthcare and promote equitable health outcomes for all members of society.
This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reduced Inequalities by emphasizing the importance of technology assessment capability in shaping health policy and priorities to improve health outcomes and quality of life. By promoting strong professional education and practice standards, accreditation processes, and educational programs for public health, the content supports efforts to enhance the quality of healthcare services and public health interventions. Additionally, it aligns with Goal 10: Reduced Inequalities by recognizing the need to address disparities and ensure equitable access to evidence-based methods of prevention, diagnosis, and therapy. By advocating for continuous revision of legal frameworks and ethical standards in response to societal changes and emerging health challenges, the content underscores the importance of promoting fairness and equity in public health practices and policies. Moreover, it highlights the ethical imperative of public health interventions to protect populations from illness and premature death, thereby contributing to efforts aimed at reducing inequalities in health outcomes and promoting the well-being of all members of society.
The Global Alliance for Genomics and Health (GA4GH) is an international standards development organization (SDO) focused on advancing human health and medicine through genomic data sharing and interoperability. Founded in 2013, the organization has evolved over time and has adapted to unexpected challenges in ways that we believe would be of interest to the broad biomedical community. In this chapter, we present our experiences to support others wishing to share data through global, community-driven standards supporting SDG3.

Pages